Mark E. Burkard, Ph.D.
Affiliations: | 2000 | University of Rochester, Rochester, NY |
Area:
BiochemistryGoogle:
"Mark Burkard"Mean distance: (not calculated yet)
Parents
Sign in to add mentorDouglas H. Turner | grad student | 2000 | Rochester | |
(Base stacking interactions and the thermodynamics and structure of guanine -guanine pairs in RNA.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Denu RA, Burkard ME. (2020) Analysis of the "centrosome-ome" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer. Scientific Reports. 10: 11921 |
Sharick JT, Walsh CM, Sprackling CM, et al. (2020) Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment. Frontiers in Oncology. 10: 553 |
Singh A, Denu RA, Wolfe SK, et al. (2020) Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancer. Molecular Oncology |
Parsons BM, Meier DR, Richmond CS, et al. (2020) Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer. Clinical Breast Cancer |
Emmerich P, Matkowskyj KA, McGregor S, et al. (2020) VCAN accumulation and proteolysis as predictors of T lymphocyte-excluded and permissive tumor microenvironments. Journal of Clinical Oncology. 38: 3127-3127 |
Rocque G, Gilbert A, Williams CP, et al. (2020) Abstract P2-15-05: Visualization of the relationship between survival and sequential treatments in metastatic breast cancer Cancer Research. 80 |
Wildiers H, Boni V, Saura C, et al. (2020) Abstract P1-19-08: Neratinib + trastuzumab + fulvestrant for HER2-mutant, hormone receptor-positive, metastatic breast cancer: Updated results from the phase 2 SUMMIT ‘basket’ trial Cancer Research. 80 |
Hu Y, Jin N, Manasrah BK, et al. (2020) Abstract 2248: Paclitaxel-induced micronucleation activates pro-inflammatory cGAS/STING signaling in triple negative breast cancer Immunology |
Pasch CA, Favreau PF, Yueh AE, et al. (2019) Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Gilbert A, Kandhare P, Nakhmani A, et al. (2019) Utilizing visualization to qualitatively evaluate electronic health record-derived database limitations. Journal of Clinical Oncology. 37: 317-317 |